AZN - Artelo Biosciences names Andrew Yates Chief Scientific Officer

Artelo Biosciences (ARTL) names former AstraZeneca (AZN) executive Andrew Yates as its Senior Vice President and Chief Scientific Officer. Yates had held significant roles across a number of functional areas including development and commercial strategy, medical affairs, and business development.He will be responsible for advancing the company’s research and development, oversee engagement with the Scientific Advisory Board, and serve as a key member of Artelo’s executive management team.shares up nearly 5% premarket.

For further details see:

Artelo Biosciences names Andrew Yates Chief Scientific Officer